Latest Breaking News On - Treatment approaches in mental health - Page 1 : comparemela.com

Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium

Small Pharma to Participate in Upcoming Canaccord Genuity Investor Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomCanaccord genuityEric ribnerlifesci advisorsemailJaber mohamedmhp communicationsemailGeorge tzirasCarol routledgeCompany or small pharmaSmall pharma incRegulation services providerVenture exchangeTreatment approaches in mental healthRegulatory agencyWall streetChief executive officerChief medical

News snapshot: BioVie, Delta 9 Cannabis, Sigma Lithium, Plurilock, Mandalay Resources, NexTech AR

News snapshot: BioVie, Delta 9 Cannabis, Sigma Lithium, Plurilock, Mandalay Resources, NexTech AR
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan hoylesJames lanthierPatrick powerGerald commissiongBrad dunnDavid neuhauserJoseph araujoAndrew partheniouStefan gleasonKirk herringtonJames edward capital corporationTodos medical ltdNevada silver corporationStar manganese incMysize inc

Seelos Therapeutics to Participate in Canaccord Genuity s New Paradigms and Treatment Approaches in Mental Health Conference February 3-4

Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health virtual conference, Wednesday, February 3 rd and Thursday, February 4 th 2021. Raj Mehra, Ph.D., Chairman and CEO, will present on … Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health virtual conference, Wednesday, February 3 rd and Thursday, February 4 th 2021.

New yorkUnited statesRaj mehraAnthony marcianoJavelin pharmaceuticals inc hospiraSeelos therapeutics incTreatment approaches in mental healthExchange commissionHead of corporate communicationsNational suicide prevention lifelineAgency for healthcare researchSeelos therapeuticsCanaccord genuityNew paradigmsTreatment approachesMental health